These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 17682574)

  • 41. Prescription drugs and medical costs: four opportunities for health plans and physicians to make a difference.
    Greczyn RJ
    N C Med J; 2003; 64(6):285-6. PubMed ID: 14983619
    [No Abstract]   [Full Text] [Related]  

  • 42. An audit of drug prescribing practices of dentists.
    Sarkar C; Das B; Baral P
    Indian J Dent Res; 2004; 15(2):58-61. PubMed ID: 15751782
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cost-effectiveness of intensive atorvastatin treatment in high-risk patients compared with usual care in a postgeneric statin market: economic analysis of the Aggressive Lipid-lowering Initiation Abates New Cardiac Events (ALLIANCE) study.
    Mullins CD; Rattinger GB; Kuznik A; Koren MJ
    Clin Ther; 2008; 30 Pt 2():2204-16. PubMed ID: 19281915
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Generic drug utilisation on the General Medical Services (GMS) scheme in 2001.
    Tilson L; McGowan B; Ryan M; Barry M
    Ir Med J; 2003 Jun; 96(6):176-9. PubMed ID: 12926759
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The rise of the generic drug market and its implications for dermatology.
    Bhosle M; Balkrishnan R; Dewan T; Yelverton CB; Feldman SR
    J Dermatolog Treat; 2005; 16(5-6):295-8. PubMed ID: 16428148
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Training on the Practical Approach to Lung Health: effect on drug prescribing in PHC settings in Jordan.
    Abu Rumman K; Ottmani S; Abu Sabra N; Baghdadi S; Seita A; Blanc L
    East Mediterr Health J; 2009; 15(1):111-21. PubMed ID: 19469433
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Out-of-pocket costs to users: medicine options for hypertension.
    Arredondo A
    Am J Hypertens; 2008 May; 21(5):492. PubMed ID: 18437138
    [No Abstract]   [Full Text] [Related]  

  • 48. [Induced drug prescription in oncology patients].
    Mas Arcas C; Pascual Plá F; Escrivá Muñz JJ; Boscas Mayans R
    Farm Hosp; 2004; 28(2):97-100. PubMed ID: 15101800
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prescription patterns analysis--variations among Bulgaria, Romania, Macedonia and Bosnia Herzegovina.
    Petrova GI
    Cent Eur J Public Health; 2002 Sep; 10(3):100-3. PubMed ID: 12298339
    [TBL] [Abstract][Full Text] [Related]  

  • 50. What are the obstacles to generic substitution? An assessment of the behaviour of prescribers, patients and pharmacies during the first year of generic substitution in Sweden.
    Andersson K; Sonesson C; Petzold M; Carlsten A; Lönnroth K
    Pharmacoepidemiol Drug Saf; 2005 May; 14(5):341-8. PubMed ID: 15624198
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Pharmaco-therapeutic evaluation of medical treatments of adult autistics and multi-handicapped patients in a public mental health unit].
    Armand-Branger S; Poisson N; Gaudoneix-Taïeb M; Ramos O
    Encephale; 2009 Sep; 35(4):370-6. PubMed ID: 19748374
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dispensing pattern of generic and brand-name drugs in children.
    Chen AY; Wu S
    Ambul Pediatr; 2008; 8(3):189-94. PubMed ID: 18501866
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cost-related medication underuse: do patients with chronic illnesses tell their doctors?
    Piette JD; Heisler M; Wagner TH
    Arch Intern Med; 2004 Sep; 164(16):1749-55. PubMed ID: 15364667
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Current approaches to the use of generic antiepileptic drugs.
    Krämer G; Biraben A; Carreno M; Guekht A; de Haan GJ; Jedrzejczak J; Josephs D; van Rijckevorsel K; Zaccara G
    Epilepsy Behav; 2007 Aug; 11(1):46-52. PubMed ID: 17537678
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Changing prescribing patterns: a program of physician education.
    Whiteside ME; Lefkowitz S; Justiniani FR; Ratzan K
    Hosp Formul; 1987 Jun; 22(6):561-3, 566, 568. PubMed ID: 10282249
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prescription of diuretic drugs and monitoring of long-term use in one general practice.
    Rhodes KE
    Br J Gen Pract; 1992 Feb; 42(355):68-70. PubMed ID: 1493009
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Teaching exercise of drug utilization by medical students.
    Das BP; Sethi A; Nutan K; Gunjan
    JNMA J Nepal Med Assoc; 2005; 44(160):160-4. PubMed ID: 18380068
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Psychiatrists' decision making between branded and generic drugs.
    Hamann J; Mendel R; Kissling W; Leucht S
    Eur Neuropsychopharmacol; 2013 Jul; 23(7):686-90. PubMed ID: 23021566
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence of potential drug-drug interactions and its associated factors in a Brazilian teaching hospital.
    Cruciol-Souza JM; Thomson JC
    J Pharm Pharm Sci; 2006; 9(3):427-33. PubMed ID: 17207423
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prescribing patterns for upper respiratory tract infections in general practice in France and in the Netherlands.
    Rosman S; Le Vaillant M; Schellevis F; Clerc P; Verheij R; Pelletier-Fleury N
    Eur J Public Health; 2008 Jun; 18(3):312-6. PubMed ID: 18160392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.